Supraspinatus Tendinosis.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Have a confirmed diagnosis of supraspinatus tendinosis. All participants must be medically stable, conscious, and ambulant at the time of inclusion Should not have any pre-existing neurological disorders that could interfere with the study.
Exclusion criteria
Exclusion criteria: Patients who are unwilling to continue treatment sessions or are unable to provide informed consent will be excluded from the study. Participants with any other existing shoulder disorders or a history of previous shoulder surgery will also be excluded. Patients who have received of intra-articular injection within the past three months. Patients who have the Presence of metal implants or malignancy in the affected area. Patients who have an acute infection at the treatment site. Patients with the following conditions will likewise not be eligible for participation: Diabetes mellitus, Bone infection, Shoulder instability, Rheumatological diseases such as rheumatoid arthritis and gouty arthritis. Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity (at rest and during activity), shoulder pain and functional disability, active shoulder abduction ROM. Timepoint: The interventions will be administered over a period of 4 weeks, 3 sessions per week. Assessments will be conducted by a blinded assessor at the beginning and immediately After the treatment period. Method of measurement: Visual Analogue Scale (VAS), for measuring subjective pain levels. Shoulder Pain and Disability Index (SPADI). measures shoulder pain and functional disability. Goniometer for measuring active shoulder abduction range of motion (ROM). | — |
Secondary
| Measure | Time frame |
|---|---|
| Medio-lateral inferior angle displacement and scapular asymmetry. Timepoint: The interventions will be administered over a period of 4 weeks, 3 sessions per week. Assessments will be conducted by a blinded assessor at the beginning and immediately After the treatment period. Method of measurement: The Lateral Scapular Slide Test (LSST). | — |
Countries
Iraq
Contacts
Tehran University of Medical Sciences